Inventor · disambiguated record
Joseph E. Pero
Also filed as: PERO JOSEPH · PERO JOSEPH E
18 granted patents·6 pending applications·32 citations·filing 2011–2024
89Inventor score
Files withGLAXOSMITHKLINE IP DEV LTD10GLAXOSMITHKLINE IP NO 2 LTD4MERCK SHARP & DOHME3ARRINGTON KENNETH L1BRESLIN MICHAEL J1
Top patents by PatentIndex Score
24 records- 0190US8765784B2Positive allosteric modulators of MGLUR2ARRINGTON KENNETH L·Filed 2011·Granted Jul 1, 2014·20 cites·19 claims
- 0284US2024300965A1CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0382US8975261B2Aryloxmethyl cyclopropane derivatives as PDE10 inhibitorsBRESLIN MICHAEL J·Filed 2012·Granted Mar 10, 2015·4 cites·13 claims
- 0477US10364256B2Biaryl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 30, 2019·2 cites·15 claims
- 0574US2025092053A1Triazole-substituted imidazo[1,2-a]pyrimidines as cgas inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Application pending·0 cites
- 0673US12247033B2Triazole-substituted imidazo[1,2-a]pyrimidines as cGAS inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2024·Granted Mar 11, 2025·0 cites·28 claims
- 0770US10125141B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Nov 13, 2018·1 cites·30 claims
- 0870US9624208B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2013·Granted Apr 18, 2017·1 cites·5 claims
- 0969US10588891B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 17, 2020·1 cites·21 claims
- 1068US11999746B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Jun 4, 2024·0 cites·14 claims
- 1166US8993779B2Positive allosteric modulators of MGLUR2DUDKIN VADIM Y·Filed 2011·Granted Mar 31, 2015·1 cites·9 claims
- 1264US9388179B2N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2013·Granted Jul 12, 2016·1 cites·20 claims
- 1362US9273040B2Benzoxazolinone compounds with selective activity in voltage-gated sodium channelsLAYTON MARK E·Filed 2012·Granted Mar 1, 2016·1 cites·22 claims
- 1461US10428078B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 1, 2019·0 cites·28 claims
- 1553US11229623B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Jan 25, 2022·0 cites·21 claims
- 1645US2021253528A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1741US2020071310A1N-aryl pyrazoles as nrf2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1840US10442778B2N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME·Filed 2017·Granted Oct 15, 2019·0 cites·18 claims
- 1939US11260049B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 1, 2022·0 cites·28 claims
- 2039US10590077B2TRPV4 antagonistsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2017·Granted Mar 17, 2020·0 cites·20 claims
- 2139US2020031820A13-carboxylic acid pyrroles as nrf2 regulatorsGLSXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD·Filed 2017·Application pending·0 cites
- 2237US10351530B2Arylcyclohexyl pyrazoles as NRF2 regulatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Jul 16, 2019·0 cites·8 claims
- 2335US9315518B2Imidazopyridin-2-one derivativesFIJI HANNAH D·Filed 2012·Granted Apr 19, 2016·0 cites·9 claims
- 2435US2013203756A1Isoindoline pde10 inhibitorsBUNDA JAMIE L·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph E. Pero files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →